Clinical Trials Directory

Trials / Completed

CompletedNCT02698917

Carbon Dioxide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation

Carbon Dioxide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation - Targeting High vs. Low Normal Values

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The COMACARE trial is a pilot multicenter randomized trial to assess the feasibility and effect on brain injury markers of targeting low or high normal arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2) and mean arterial pressure (MAP) in comatose, mechanically ventilated patients after out-of-hospital cardiac arrest. Using factorial design, participants are randomized at admission to intensive care unit to one of eight groups targeting either low or high normal values of PaO2, PaCO2 and MAP for 36 h. In this way, investigators will be assessing the feasibility and effect of all three variables at the same time. The primary outcome is serum concentration of neuron-specific enolase (NSE) at 48 h after cardiac arrest. Feasibility outcome is between-group separation in PaO2, PaCO2 and MAP levels. Secondary outcomes include continuous monitoring of cerebral oxygenation, EEG and ECG for 48 h, the levels of NSE, S100B and cardiac troponin at randomization and 24, 48 and 72 h after cardiac arrest and neurological assessment at 6 months after cardiac arrest.

Conditions

Interventions

TypeNameDescription
OTHERLow normal PaCO24.5-4.7 kPa
OTHERHigh normal PaCO25.8-6.0 kPa
OTHERLow normal PaO210-15 kPa
OTHERHigh normal PaO220-25 kPa
OTHERLow normal MAP65-75 mmHg
OTHERHigh normal MAP80-100 mmHg

Timeline

Start date
2016-03-22
Primary completion
2017-11-03
Completion
2018-05-03
First posted
2016-03-04
Last updated
2018-08-03

Locations

7 sites across 2 countries: Denmark, Finland

Source: ClinicalTrials.gov record NCT02698917. Inclusion in this directory is not an endorsement.